Helmerich & Payne, Inc. HP revenue by segment, product and geography
In its fiscal year ending 2025-09-30, Helmerich & Payne, Inc. reported revenue across 1 products and services; the largest, Reimbursements Of Out Of Pocket Expenses, was $431M, 100.0% of the filed sum (+28.9% against the prior period in the same filing).
Reported segment mix
figures as filed · share of the filed sum · change vs the prior period in the same filing- Reimbursements Of Out Of Pocket Expenses$431M100.0%+28.9% yoy
Members sum to $431M against $3.68B consolidated (residual $3.25B) - eliminations or corporate lines the filer did not tag on this axis.
- United States$2.48B66.2%-3.0% yoy
- SA$262M7.0%no prior
- NO$220M5.9%no prior
- OM$180M4.8%no prior
- Other Foreign$163M4.4%+480.2% yoy
- AR$156M4.2%+9.3% yoy
- AZ$129M3.4%no prior
- Germany$57.6M1.5%no prior
- +3 more members in the filing
Members sum to the consolidated $3.68B for this period.
- United States$548M58.8%-6.9% yoy
- Other Foreign$87M9.3%-10.7% yoy
- NO$86M9.2%+9.9% yoy
- SA$65.6M7.0%-30.7% yoy
- OM$63.2M6.8%-9.2% yoy
- AZ$46.8M5.0%+9.3% yoy
- +1 more member in the filing
Change is against the same quarter a year earlier, as reported in the same 10-Q.
Source: SEC DERA Financial Statement and Notes data sets. Dimensional XBRL facts on the business-segment, product/service and geographic axes; the engine keeps the accession of every figure. Descriptive and educational, not advice.
About these figures
Companies tag segment, product and geographic revenue as dimensional XBRL facts in their 10-K and 10-Q filings. The SEC publishes those facts in its DERA Financial Statement and Notes data sets; TrendNalysis ingests each monthly file and serves the facts exactly as filed, keyed to the accession of the filing. Shares are of the filed sum. Where a filer tags more than one breakdown on one axis, the sum exceeds consolidated revenue and no shares are computed; where the members do not add up to the consolidated figure, the residual is stated rather than hidden. Missing is never zero.
Descriptive and educational; not investment advice. Methodology and data lineage.